Skip to main content
. 2021 Mar 9;10(3):601. doi: 10.3390/cells10030601

Table 6.

The genotype distribution of IL-9: rs1859430, rs2069870, rs11741137, rs2069885, and rs2069884, according to the 1-, 3-, and 5-year LSCC-specific survival rate.

Polymorphism Genotype N = 300 (%) Survival Rate (%) p-Value 2,*
1-Year LSCC 1-Specific Survival (%) 3-Year LSCC 1-Specific Survival (%) 5-Year LSCC 1-Specific Survival (%)
IL-9 rs1859430 AA 17 (5.7) 88 45 45 0.188
0.026 **
AG 95 (31.7) 81 74 69
GG 188 (62.6) 85 71 65
IL-9 rs2069870 AA 191 (63.7) 84 71 64 0.853
AG 109 (63.7) 83 68 66
IL-9 rs1174113 CC 210 (70.0) 85 71 65 0.619
CT 81 (27.0) 79 67 64
TT 9 (3.0) 100 76 76
IL-9 rs2069885 AA 9 (3.0) 100 76 76 0.640
GA 78 (26.0) 79 67 64
GG 213 (71.0) 85 71 65
IL-9 rs2069884 GG 213 (71.0) 85 71 65 0.640
GT 782 (26.0) 79 67 64
TT 9 (3.0) 100 76 76

1 LSCC: laryngeal squamous cell carcinoma; 2 p-Value: significance level p < 0.05; * Gehan’s criterion; ** AA vs. AG and GG.